New vaccine developed by BioNTech and Genentech could prevent deadliest cancer pancreatic returning - Daily Mail

Early trial results suggest the personalised vaccines prime the body to stop the deadly disease coming back. Only a quarter of patients survive for a year or more after pancreatic cancer diagnosis.

Experts have hailed a cutting-edge vaccine that could prevent pancreatic cancer from returning.  Early trial results suggest the personalised vaccines prime the body to stop the deadly disease comin… [+3473 chars]

full article...